Artykuły w czasopismach na temat „Surveillance immune”

Kliknij ten link, aby zobaczyć inne rodzaje publikacji na ten temat: Surveillance immune.

Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych

Wybierz rodzaj źródła:

Sprawdź 50 najlepszych artykułów w czasopismach naukowych na temat „Surveillance immune”.

Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.

Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.

Przeglądaj artykuły w czasopismach z różnych dziedzin i twórz odpowiednie bibliografie.

1

Shastri, Nilabh, Chansu Park i Jian Guan. "Immune surveillance of immune surveillance". Molecular Immunology 150 (październik 2022): 2. http://dx.doi.org/10.1016/j.molimm.2022.05.018.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
2

Swann, Jeremy B., i Mark J. Smyth. "Immune surveillance of tumors". Journal of Clinical Investigation 117, nr 5 (1.05.2007): 1137–46. http://dx.doi.org/10.1172/jci31405.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
3

Grossman, Zvi, i Ronald B. Herberman. "‘Immune surveillance’ without immunogenicity". Immunology Today 7, nr 5 (maj 1986): 128–31. http://dx.doi.org/10.1016/0167-5699(86)90075-7.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
4

Prehn, Richmond T., i Liisa M. Prehn. "The flip side of immune surveillance: immune dependency". Immunological Reviews 222, nr 1 (kwiecień 2008): 341–56. http://dx.doi.org/10.1111/j.1600-065x.2008.00609.x.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
5

Kim, Ryungsa, Manabu Emi i Kazuaki Tanabe. "Cancer immunoediting from immune surveillance to immune escape". Immunology 121, nr 1 (maj 2007): 1–14. http://dx.doi.org/10.1111/j.1365-2567.2007.02587.x.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
6

Schaller, Julien, i Judith Agudo. "Metastatic Colonization: Escaping Immune Surveillance". Cancers 12, nr 11 (16.11.2020): 3385. http://dx.doi.org/10.3390/cancers12113385.

Pełny tekst źródła
Streszczenie:
Cancer immunotherapy has shifted the paradigm in cancer therapy by revitalizing immune responses against tumor cells. Specifically, in primary tumors cancer cells evolve in an immunosuppressive microenvironment, which protects them from immune attack. However, during tumor progression, some cancer cells leave the protective tumor mass, disseminating and seeding secondary organs. These initial disseminated tumor cells (DTCs) should potentially be susceptible to recognition by the immune system in the new host tissues. Although Natural Killer or T cells eliminate some of these DTCs, a fraction escape anti-tumor immunity and survive, thus giving rise to metastatic colonization. How DTCs interact with immune cells and the underpinnings that regulate imperfect immune responses during tumor dissemination remain poorly understood. Uncovering such mechanisms of immune evasion may contribute to the development of immunotherapy specifically targeting DTCs. Here we review current knowledge about systemic and site-specific immune-cancer crosstalk in the early steps of metastasis formation. Moreover, we highlight how conventional cancer therapies can shape the pre-metastatic niche enabling immune escape of newly arrived DTCs.
Style APA, Harvard, Vancouver, ISO itp.
7

Lowe, Scott. "Immune Surveillance of Senescent Cells". Innovation in Aging 5, Supplement_1 (1.12.2021): 246. http://dx.doi.org/10.1093/geroni/igab046.952.

Pełny tekst źródła
Streszczenie:
Abstract Cellular senescence involves a stable cell cycle arrest and a secretory program that modulates the tissue environment. In cancer, senescence acts as a potent barrier to tumorigenesis and, though many cancers evade senescence during the course of tumor evolution, ionizing radiation and conventional chemotherapy can, to varying degrees, induce senescence in tumor cells leading to potent anticancer effects. Conversely, the aberrant accumulation of senescent cells can reduce regenerative capacity and lead to tissue decline, contributing to tissue pathologies associated with age or the debilitating side-effects of cancer therapy. Our laboratory studies mechanisms of cellular senescence with the ultimate goal of developing strategies to modulate senescence for therapeutic benefit. We have focused on how senescent cells trigger immune surveillance to facilitate their own elimination or, when that fails, how synthetic immune cells (i.e. CAR T cells) can be directed to eliminate senescent cells. Recent advances in understanding senescent cell surveillance by the immune system will be discussed.
Style APA, Harvard, Vancouver, ISO itp.
8

Ahmad, Aamir. "Tumor microenvironment and immune surveillance". Microenvironment and Microecology Research 4, nr 1 (2022): 6. http://dx.doi.org/10.53388/mmr2022006.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
9

Oh, Julia, i Derya Unutmaz. "Immune cells for microbiota surveillance". Science 366, nr 6464 (24.10.2019): 419–20. http://dx.doi.org/10.1126/science.aaz4014.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
10

Zanetti, M., i N. R. Mahadevan. "Immune Surveillance from Chromosomal Chaos?" Science 337, nr 6102 (27.09.2012): 1616–17. http://dx.doi.org/10.1126/science.1228464.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
11

Alderton, Gemma. "Immune surveillance of the brain". Science 366, nr 6472 (19.12.2019): 1467.18–1469. http://dx.doi.org/10.1126/science.366.6472.1467-r.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
12

Zinkernagel, Rolf, i Paul Klenerman. "Immune surveillance and AIDS progression". Current Biology 7, nr 7 (lipiec 1997): R403—R405. http://dx.doi.org/10.1016/s0960-9822(06)00201-6.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
13

Nagarajan, Niranjana A., i Nilabh Shastri. "Immune surveillance for ERAAP dysfunction". Molecular Immunology 55, nr 2 (wrzesień 2013): 120–22. http://dx.doi.org/10.1016/j.molimm.2012.10.006.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
14

Schmid, Dorothee, i Christian Münz. "Immune Surveillance via Self Digestion". Autophagy 3, nr 2 (27.03.2007): 133–35. http://dx.doi.org/10.4161/auto.3591.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
15

Branch, Pauline, David C. Bicknell, Andrew Rowan, Walter F. Bodmer i Peter Karran. "Immune surveillance in colorectal carcinoma". Nature Genetics 9, nr 3 (marzec 1995): 231–32. http://dx.doi.org/10.1038/ng0395-231.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
16

Jenne, Craig N., i Paul Kubes. "Immune surveillance by the liver". Nature Immunology 14, nr 10 (18.09.2013): 996–1006. http://dx.doi.org/10.1038/ni.2691.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
17

Zanetti, Maurizio. "Chromosomal chaos silences immune surveillance". Science 355, nr 6322 (19.01.2017): 249–50. http://dx.doi.org/10.1126/science.aam5331.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
18

Ferrone, S. "Melanoma, immune surveillance, and immunotherapy." Journal of Clinical Investigation 93, nr 4 (1.04.1994): 1351–52. http://dx.doi.org/10.1172/jci117108.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
19

Damhofer, Helene, i Kristian Helin. "EZH2i unlocks PDAC immune surveillance". Nature Cancer 4, nr 6 (27.06.2023): 781–83. http://dx.doi.org/10.1038/s43018-023-00562-7.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
20

Caruso, Roberta, i Grace Y. Chen. "High fat stems tumor immune surveillance". Cell Reports Medicine 2, nr 12 (grudzień 2021): 100483. http://dx.doi.org/10.1016/j.xcrm.2021.100483.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
21

Oluwadara, Oluwadayo O., Andre Barkhordarian, Luca Giacomelli, Xenia Brant i Francesco Chiappelli. "Immune surveillance of nasopharyngeal carcinoma (NpC)". Bioinformation 7, nr 5 (31.10.2011): 271–75. http://dx.doi.org/10.6026/97320630007271.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
22

Jobim, Mariana, i Luiz F. J. Jobim. "Natural killer cells and immune surveillance". Jornal de Pediatria 84, nr 7 (29.09.2008): 58–67. http://dx.doi.org/10.2223/jped.1780.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
23

Monzavi-Karbassi, Behjatolah, Anastas Pashov i Thomas Kieber-Emmons. "Tumor-Associated Glycans and Immune Surveillance". Vaccines 1, nr 2 (17.06.2013): 174–203. http://dx.doi.org/10.3390/vaccines1020174.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
24

Shin, Hwain, Manuela Mally, Marina Kuhn, Cecile Paroz i Guy R. Cornelis. "Escape from Immune Surveillance byCapnocytophaga canimorsus". Journal of Infectious Diseases 195, nr 3 (luty 2007): 375–86. http://dx.doi.org/10.1086/510243.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
25

Gruenbacher, Georg, i Martin Thurnher. "Mevalonate metabolism governs cancer immune surveillance". OncoImmunology 6, nr 10 (27.07.2017): e1342917. http://dx.doi.org/10.1080/2162402x.2017.1342917.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
26

Eiselein, M. W. Biggs and J. E. "Suppression of immune surveillance in melanoma". Medical Hypotheses 56, nr 6 (czerwiec 2001): 648–52. http://dx.doi.org/10.1054/mehy.2000.1211.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
27

Smyth, Mark J., Ilia Voskoboinik i Joseph A. Trapani. "Immune surveillance of lymphoma in humans?" Blood 105, nr 11 (1.06.2005): 4159–60. http://dx.doi.org/10.1182/blood-2005-03-1019.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
28

den Hartog, Gerco, Rob van Binnendijk, Anne-Marie Buisman, Guy A. M. Berbers i Fiona R. M. van der Klis. "Immune surveillance for vaccine-preventable diseases". Expert Review of Vaccines 19, nr 4 (29.03.2020): 327–39. http://dx.doi.org/10.1080/14760584.2020.1745071.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
29

Agranovich, Alexandra, Tal Vider-Shalit i Yoram Louzoun. "Optimal viral immune surveillance evasion strategies". Theoretical Population Biology 80, nr 4 (grudzień 2011): 233–43. http://dx.doi.org/10.1016/j.tpb.2011.08.005.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
30

Pawelec, Graham. "MHC-Unrestricted Immune Surveillance of Leukemia1". Cancer Biotherapy 9, nr 3 (styczeń 1994): 265–88. http://dx.doi.org/10.1089/cbr.1994.9.265.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
31

Starck, S. R., S. Cardinaud i N. Shastri. "Immune surveillance obstructed by viral mRNA". Proceedings of the National Academy of Sciences 105, nr 27 (1.07.2008): 9135–36. http://dx.doi.org/10.1073/pnas.0804456105.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
32

Mahasa, Khaphetsi Joseph, Rachid Ouifki, Amina Eladdadi i Lisette de Pillis. "Mathematical model of tumor–immune surveillance". Journal of Theoretical Biology 404 (wrzesień 2016): 312–30. http://dx.doi.org/10.1016/j.jtbi.2016.06.012.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
33

Newcombe, D. S. "Immune surveillance, organophosphorus exposure, and lymphomagenesis". Lancet 339, nr 8792 (luty 1992): 539–41. http://dx.doi.org/10.1016/0140-6736(92)90349-8.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
34

Chow, Melvyn T., Andreas Möller i Mark J. Smyth. "Inflammation and immune surveillance in cancer". Seminars in Cancer Biology 22, nr 1 (luty 2012): 23–32. http://dx.doi.org/10.1016/j.semcancer.2011.12.004.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
35

Noble, Kim A. "Rheumatoid Arthritis: Immune Surveillance Gone Wild?" Journal of PeriAnesthesia Nursing 26, nr 2 (kwiecień 2011): 110–15. http://dx.doi.org/10.1016/j.jopan.2011.01.008.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
36

Kandalaft, Lana E., Gregory T. Motz, Jaikumar Duraiswamy i George Coukos. "Tumor immune surveillance and ovarian cancer". Cancer and Metastasis Reviews 30, nr 1 (8.02.2011): 141–51. http://dx.doi.org/10.1007/s10555-011-9289-9.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
37

Boyd, Ashleigh S., i Neil P. Rodrigues. "Stem Cells Cycle toward Immune Surveillance". Immunity 48, nr 2 (luty 2018): 187–90. http://dx.doi.org/10.1016/j.immuni.2018.02.006.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
38

Young, Richard A., i Timothy J. Elliott. "Stress proteins, infection, and immune surveillance". Cell 59, nr 1 (październik 1989): 5–8. http://dx.doi.org/10.1016/0092-8674(89)90861-1.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
39

Zimmermann, Valerie S., Fabio Benigni i Anna Mondino. "Immune surveillance and anti-tumor immune responses: an anatomical perspective". Immunology Letters 98, nr 1 (kwiecień 2005): 1–8. http://dx.doi.org/10.1016/j.imlet.2004.09.005.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
40

Garcia-Lora, Angel, Ignacio Algarra i Federico Garrido. "MHC class I antigens, immune surveillance, and tumor immune escape". Journal of Cellular Physiology 195, nr 3 (2003): 346–55. http://dx.doi.org/10.1002/jcp.10290.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
41

Töpfer, Katrin, Stefanie Kempe, Nadja Müller, Marc Schmitz, Michael Bachmann, Marc Cartellieri, Gabriele Schackert i Achim Temme. "Tumor Evasion from T Cell Surveillance". Journal of Biomedicine and Biotechnology 2011 (2011): 1–19. http://dx.doi.org/10.1155/2011/918471.

Pełny tekst źródła
Streszczenie:
An intact immune system is essential to prevent the development and progression of neoplastic cells in a process termed immune surveillance. During this process the innate and the adaptive immune systems closely cooperate and especially T cells play an important role to detect and eliminate tumor cells. Due to the mechanism of central tolerance the frequency of T cells displaying appropriate arranged tumor-peptide-specific-T-cell receptors is very low and their activation by professional antigen-presenting cells, such as dendritic cells, is frequently hampered by insufficient costimulation resulting in peripheral tolerance. In addition, inhibitory immune circuits can impair an efficient antitumoral response of reactive T cells. It also has been demonstrated that large tumor burden can promote a state of immunosuppression that in turn can facilitate neoplastic progression. Moreover, tumor cells, which mostly are genetically instable, can gain rescue mechanisms which further impair immune surveillance by T cells. Herein, we summarize the data on how tumor cells evade T-cell immune surveillance with the focus on solid tumors and describe approaches to improve anticancer capacity of T cells.
Style APA, Harvard, Vancouver, ISO itp.
42

Guan, Jian, Josiah David Peske, Joshua A. Taylor i Nilabh Shastri. "The nonclassical immune surveillance for ERAAP function". Current Opinion in Immunology 70 (czerwiec 2021): 105–11. http://dx.doi.org/10.1016/j.coi.2021.05.008.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
43

Ousman, Shalina S., i Paul Kubes. "Immune surveillance in the central nervous system". Nature Neuroscience 15, nr 8 (26.07.2012): 1096–101. http://dx.doi.org/10.1038/nn.3161.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
44

Prolo, P., F. Chiappelli, G. Bernard, M. Fiala, A. Ibarra, M. L. Sartori, A. Dovio i A. Angeli. "Neuroendocrine-Immune Surveillance of Osteosarcoma: Emerging Hypothesis". Journal of Dental Research 82, nr 6 (czerwiec 2003): 417–21. http://dx.doi.org/10.1177/154405910308200603.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
45

Moser, B. "Chemokines: role in inflammation and immune surveillance". Annals of the Rheumatic Diseases 63, suppl_2 (1.11.2004): ii84—ii89. http://dx.doi.org/10.1136/ard.2004.028316.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
46

Schmid, D., i C. Münz. "Immune surveillance of intracellular pathogens via autophagy". Cell Death & Differentiation 12, S2 (25.10.2005): 1519–27. http://dx.doi.org/10.1038/sj.cdd.4401727.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
47

Kim, Tae Hyun, i Sang Geon Kim. "Role of CXCR6 in Antitumor Immune Surveillance". Gastroenterology 156, nr 6 (maj 2019): 1565–68. http://dx.doi.org/10.1053/j.gastro.2019.03.032.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
48

Di Francesco, P., F. Pica, L. Belogi, C. Croce, C. Favalli, E. Tubaro i E. Garaci. "Influence of cocaine on murine immune surveillance". Pharmacological Research 22 (wrzesień 1990): 165. http://dx.doi.org/10.1016/s1043-6618(09)80208-9.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
49

Feinberg, Mark B., i Angela R. McLean. "AIDS: Decline and fall of immune surveillance?" Current Biology 7, nr 3 (marzec 1997): R136—R140. http://dx.doi.org/10.1016/s0960-9822(97)70072-1.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
50

Wekerle, Hartmut. "Immune reactivity and surveillance in the CNS". Journal of Neuroimmunology 38, nr 1-2 (maj 1992): 179. http://dx.doi.org/10.1016/0165-5728(92)90123-3.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
Oferujemy zniżki na wszystkie plany premium dla autorów, których prace zostały uwzględnione w tematycznych zestawieniach literatury. Skontaktuj się z nami, aby uzyskać unikalny kod promocyjny!

Do bibliografii